Compare AVAV & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAV | HIMS |
|---|---|---|
| Founded | 1971 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Medical/Nursing Services |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0B | 12.2B |
| IPO Year | 2007 | N/A |
| Metric | AVAV | HIMS |
|---|---|---|
| Price | $278.56 | $39.53 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 11 |
| Target Price | ★ $352.21 | $44.56 |
| AVG Volume (30 Days) | 779.9K | ★ 21.3M |
| Earning Date | 12-09-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.76 |
| EPS | N/A | ★ 0.54 |
| Revenue | $1,085,820,000.00 | ★ $2,210,958,000.00 |
| Revenue This Year | $148.47 | $62.21 |
| Revenue Next Year | $17.12 | $18.79 |
| P/E Ratio | ★ N/A | $73.02 |
| Revenue Growth | 44.03 | ★ 78.02 |
| 52 Week Low | $102.25 | $23.97 |
| 52 Week High | $417.86 | $72.98 |
| Indicator | AVAV | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 40.09 | 47.70 |
| Support Level | $257.31 | $35.78 |
| Resistance Level | $292.75 | $39.87 |
| Average True Range (ATR) | 13.23 | 2.24 |
| MACD | 1.37 | 0.81 |
| Stochastic Oscillator | 54.90 | 78.91 |
AeroVironment Inc supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities. Company operates in three segments: UxS, LMS, MW.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.